Copyright Reports & Markets. All rights reserved.

Global Paliperidone Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Paliperidone Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 1.5 mg Tablet
      • 1.4.3 3 mg Tablet
      • 1.4.4 6 mg Tablet
      • 1.4.5 9 mg Tablet
    • 1.5 Market by Application
      • 1.5.1 Global Paliperidone Market Share by Application (2014-2025)
      • 1.5.2 Adults
      • 1.5.3 Adolescents
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Paliperidone Market Size
    • 2.2 Paliperidone Growth Trends by Regions
      • 2.2.1 Paliperidone Market Size by Regions (2014-2025)
      • 2.2.2 Paliperidone Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Paliperidone Market Size by Manufacturers
      • 3.1.1 Global Paliperidone Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Paliperidone Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Paliperidone Market Concentration Ratio (CR5 and HHI)
    • 3.2 Paliperidone Key Players Head office and Area Served
    • 3.3 Key Players Paliperidone Product/Solution/Service
    • 3.4 Date of Enter into Paliperidone Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Paliperidone Market Size by Type (2014-2019)
    • 4.2 Global Paliperidone Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Paliperidone Market Size (2014-2019)
    • 5.2 Paliperidone Key Players in United States
    • 5.3 United States Paliperidone Market Size by Type
    • 5.4 United States Paliperidone Market Size by Application

    6 Europe

    • 6.1 Europe Paliperidone Market Size (2014-2019)
    • 6.2 Paliperidone Key Players in Europe
    • 6.3 Europe Paliperidone Market Size by Type
    • 6.4 Europe Paliperidone Market Size by Application

    7 China

    • 7.1 China Paliperidone Market Size (2014-2019)
    • 7.2 Paliperidone Key Players in China
    • 7.3 China Paliperidone Market Size by Type
    • 7.4 China Paliperidone Market Size by Application

    8 Japan

    • 8.1 Japan Paliperidone Market Size (2014-2019)
    • 8.2 Paliperidone Key Players in Japan
    • 8.3 Japan Paliperidone Market Size by Type
    • 8.4 Japan Paliperidone Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Paliperidone Market Size (2014-2019)
    • 9.2 Paliperidone Key Players in Southeast Asia
    • 9.3 Southeast Asia Paliperidone Market Size by Type
    • 9.4 Southeast Asia Paliperidone Market Size by Application

    10 India

    • 10.1 India Paliperidone Market Size (2014-2019)
    • 10.2 Paliperidone Key Players in India
    • 10.3 India Paliperidone Market Size by Type
    • 10.4 India Paliperidone Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Paliperidone Market Size (2014-2019)
    • 11.2 Paliperidone Key Players in Central & South America
    • 11.3 Central & South America Paliperidone Market Size by Type
    • 11.4 Central & South America Paliperidone Market Size by Application

    12 International Players Profiles

    • 12.1 Janssen Pharmaceutica
      • 12.1.1 Janssen Pharmaceutica Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Paliperidone Introduction
      • 12.1.4 Janssen Pharmaceutica Revenue in Paliperidone Business (2014-2019)
      • 12.1.5 Janssen Pharmaceutica Recent Development
    • 12.2 Mylan
      • 12.2.1 Mylan Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Paliperidone Introduction
      • 12.2.4 Mylan Revenue in Paliperidone Business (2014-2019)
      • 12.2.5 Mylan Recent Development
    • 12.3 Teva
      • 12.3.1 Teva Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Paliperidone Introduction
      • 12.3.4 Teva Revenue in Paliperidone Business (2014-2019)
      • 12.3.5 Teva Recent Development
    • 12.4 Sun Pharmaceutical
      • 12.4.1 Sun Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Paliperidone Introduction
      • 12.4.4 Sun Pharmaceutical Revenue in Paliperidone Business (2014-2019)
      • 12.4.5 Sun Pharmaceutical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. It is marketed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Paliperidone is mainly used to treat schizophrenia and schizoaffective disorder. It is also used to treat mania and at lower doses as maintenance for bipolar disorder.
      In 2018, the global Paliperidone market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Paliperidone status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Paliperidone development in United States, Europe and China.

      The key players covered in this study
      Janssen Pharmaceutica
      Mylan
      Teva
      Sun Pharmaceutical
      ...

      Market segment by Type, the product can be split into
      1.5 mg Tablet
      3 mg Tablet
      6 mg Tablet
      9 mg Tablet

      Market segment by Application, split into
      Adults
      Adolescents

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Paliperidone status, future forecast, growth opportunity, key market and key players.
      To present the Paliperidone development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Paliperidone are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now